IntravasCular Imaging-Guided Versus AngiogRaphy-GUided Drug-Eluting Stent Implantation for Fermoropopliteal Artery Disease, A feasibility study

Asan Medical Center0 个研究点目标入组 100 人开始时间: 待定最近更新: 2022年2月7日

适应症

试验速览

暂无简介。

•1.20 years of age=85 years of age.
•2.Intermittent claudication or tissue loss suitable for elective endovascular intervention (Rutherford category 2,3,4, or 5)
•3.Significant native superficial femoral or proximal popliteal artery lesions suitable for stent implantation(residual angiographic stenosis =70% ). Restenotic lesions can be enrolled at least 12-month after the index procedure uding plain balloon or drug-coated balloon.
•4.Total lesion length of 30 to 220 mm
•5.Reference vessel diameter of 4 – 6 mm
•6.The patient or fuardian agrees written conenst to the study protocol.

•1.Existence of a stent in the target vessel
•2.Previous use of atherectomy device in the target vessel
•3.Use of drug-coated balloon in the target vessel within 12-month
•4.Significant stenosis or occlusion (diameter stenosis =70%) in all 3 infrapopliteal arteries
•5.A known intolerance or contraindication to antiplatelet drugs (aspirin or clopidogrel)

发起方